Oral Amino Acid Blends for Glucose Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for diabetes, such as insulin administration and dietary restrictions, often face challenges with patient compliance and side effects, and existing medications may lose effectiveness over time, failing to adequately manage blood glucose levels.
Innovation Solution
Amino acid blends comprising isoleucine, leucine, valine, cysteine, and methionine in specific weight ratios are administered to individuals with impaired glucose tolerance or diabetes, providing a blunted glycemic response to carbohydrate loads, thereby regulating blood sugar levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If insulin administration is used to treat diabetes, then blood glucose levels can be controlled, but patient compliance deteriorates due to injection requirements and side effects
Solution Approach 1:
The patent replaces the mechanical injection method with oral amino acid supplements. Instead of requiring insulin injections, the invention uses orally administered amino acid blends (specifically containing isoleucine, leucine, valine, cysteine, and methionine in defined ratios) to achieve glucose control, eliminating the mechanical barrier of injections and improving patient compliance
Solution Approach 2:
The patent changes the therapeutic approach from hormonal replacement (insulin) to nutritional supplementation (amino acids). By administering specific amino acid blends in defined amounts and ratios, the invention modifies the metabolic parameters to achieve glucose control through a different biochemical pathway, thereby improving compliance while maintaining effectiveness
2Reliability
If restrictive diets are used to manage diabetes, then blood glucose levels can be controlled, but patient compliance deteriorates due to dietary limitations
Solution Approach 1:
The patent extracts the essential therapeutic component (specific amino acids) from the complex dietary restrictions. Instead of requiring patients to follow comprehensive restrictive diets, the invention isolates and administers only the critical amino acid blend needed for glucose control, significantly simplifying the intervention and improving compliance
3Reliability
If traditional medications are used to stimulate insulin release, then blood glucose levels can be controlled, but effectiveness deteriorates after prolonged use due to loss of effectiveness
Solution Approach 1:
The patent employs amino acids that work through natural metabolic pathways rather than forcing insulin release. The amino acid blend (particularly isoleucine, leucine, and valine) activates AMPK and improves glucose uptake through cellular mechanisms that do not depend on pancreatic insulin secretion, thereby avoiding the tolerance and effectiveness loss seen with traditional insulin-stimulating medications
Data Source
AI summary
Disclosed are compositions, including low-calorie beverages or liquids, comprising isoleucine, leucine, valine, cysteine, and methionine, in specified amounts, weight ratios, or both. The compositions are especially useful in treating individuals afflicted with impaired glucose tolerance or diabetes.